Federal Register Notice: FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will meet 8/4, from 8 a.m. to 5 p.m. at the CDER Advisory Committee Conference Room, Rm. 1066, 5630 Fishers Lane, Rockville, MD. The committee will discuss a Pozen, Inc. NDA with a proposed trade name MT100 (naproxen sodium and metoclopramide hydrochloride) tablets for acute treatment of migraine headache with or without aura. Contact Anuja Patel, (301) 827-7001. To view this notice, click here.
